CDT Equity CDT
NASDAQ CDT
$0.97 -0.28 (-22.40%)
As of: Oct 2, 2026 · 1:06 PM EDT

CDT Equity (CDT) Selling, General & Administrative (2022 - 2026)

Updated

CDT Equity's Selling, General & Administrative came in at $2.7 million for Q2 2026, down 12.7% from $3.09 million a year earlier and down 6.2% from the prior quarter.

Analysis

CDT Equity (CDT) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CDT Equity reported Selling, General & Administrative of $31.49 million, up 164.8% year-over-year; for FY2025, it was $31.7 million, up 163.3% from FY2024.

  • Selling, General & Administrative has increased in each of the last three years, with a four-year compound annual growth rate of 822.3% (FY2021 to FY2025).
  • Going back by year, Selling, General & Administrative was $12.04 million in FY2024 (+132.8%), $5.17 million in FY2023 (+69.6%), $3.05 million in FY2022 and $4,381 in FY2021.
  • The five-year range for quarterly Selling, General & Administrative is $243,718 (Q1 2022) to $20.41 million (Q4 2025).
  • Year-over-year, Selling, General & Administrative increased in five of the last eight quarters, with growth averaging 146.4%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2024 (growth of 532.1%), and the weakest in Q3 2023 (a decline of 44.5%).
  • Business Quant data shows CDT's Selling, General & Administrative at $2.88 million (Q1 2026), $20.41 million (Q4 2025) and $5.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 CDT Equity 34,330.48 34,330.48 - 2.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70 Mn
Mar 31, 2026 2.88 Mn
Dec 31, 2025 20.41 Mn
Sep 30, 2025 5.50 Mn
Jun 30, 2025 3.09 Mn
Mar 31, 2025 2.70 Mn
Dec 31, 2024 3.38 Mn
Sep 30, 2024 2.72 Mn
Jun 30, 2024 3.12 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 2.34 Mn
Sep 30, 2023 430,000.00
Jun 30, 2023 888,000.00
Mar 31, 2023 1.52 Mn
Dec 31, 2022 1.72 Mn
Sep 30, 2022 775,000.00
Jun 30, 2022 249,420.00
Mar 31, 2022 243,718.00
API Access

CDT Equity Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CDT&period=max&api_key=YOUR_API_KEY